(Q41728180)

8 October 2017

1 reference

title

The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking? (English)

1 reference

intermittent claudication

8 October 2017

1 reference

1 reference

Tisi PV

1

1 reference

PubMed ID

9518994

8 October 2017

Shearman CP

series ordinal

2

1 reference

8 October 2017

1 January 1998

1 reference

European Journal of Vascular and Endovascular Surgery

8 October 2017

1 reference

8 October 2017

15

1 reference

8 October 2017

7-17

1 reference

8 October 2017

1

1 reference

Treating claudication in five words

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Physical activity and health

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Effect of daily muscular exercise in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Effect of Physical Training On Intermittent Claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Metabolic Activity of Skeletal Muscle in Patients with Peripheral Arterial Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Benefit of exercise conditioning for patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Objectifying exercise ischemia in peripheral vascular disease: a study in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Oxygen-derived free radicals in postischemic tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Role of the neutrophil in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Thromboxane A2 moderates permeability after limb ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Role of lipid mediators in the pathogenesis of skeletal muscle infarction and oedema during reperfusion after ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Reperfusion plasma contains a neutrophil activator

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Neutrophils may contribute to the morbidity and mortality of claudicants.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Reperfusion pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The ischaemic leg as a source of complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Activation and decreased deformability of neutrophils after intermittent claudication.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Interleukin-8 and neutrophil activation in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Biology and clinical relevance of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Clinical biology of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Ischaemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Regulatory functions of the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The endothelin family of peptides: local hormones with diverse roles in health and disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Endothelin-1 levels in ischaemia, reperfusion, and haemorrhagic shock in the canine infrarenal aortic revascularisation model

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Lipid peroxides and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Systemic responses in patients with intermittent claudication after treadmill exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Antioxidant consumption during exercise in intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Effect of surgery on the systemic inflammatory response to intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Excretion of thromboxane A2and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Role of the altered transmural permeability in the pathomechanism of arteriosclerosis. History of arteriosclerosis theories. Role of the altered permeability in experimental arteriosclerosis models.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

1 reference

7 January 2021

The prognostic significance of proteinuria: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Is low proteinuria an early predictor of severity of acute pancreatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Microproteinuria: response to operation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Urinary albumin excretion and blood pressure in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Urinary microalbumin as a marker for intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Pharmacological reduction of the systemically damaging effects of local ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

von Willebrand factor, endothelial cell damage and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Leukocytes and the risk of ischemic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Oxidised low density lipoproteins and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The oxidation hypothesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Genetic control of the inflammatory response induced by oxidized lipids

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Macrophages and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Interleukin-6 and the acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Fibrinogen and peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Prognostic Significance of Rheological and Biochemical Findings in Patients with Intermittent Claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Factors influencing prognosis in the surgery of peripheral vascular disease: Platelet adhesiveness, plasma fibrinogen, and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Fate of fibrinogen in human arterial intima

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Genetic and cultural inheritance of plasma fibrinogen concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Fibrinogen genotype and risk of peripheral atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Routine measurement of fibrinogen concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Response of serum interleukin-6 in patients undergoing elective surgery of varying severity.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Rheumatoid arthritis: the role of acute-phase proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Inflammation in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Comparative study of serum amyloid A protein and C-reactive protein in disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Serum amyloid A (SAA): an acute phase protein and apolipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2898%2980066-X

7 January 2021

10.1016/S1078-5884(98)80066-X

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9518994